Skip to main content
TradingNews

Market news

Ditch XLV: Capture Higher Healthcare Yields with ABBV, JNJ, BMY

Yahoo Finance Read original source (opens in a new tab)
The Story

News Summary

  • XLV, a healthcare ETF, is criticized for a low dividend yield due to its cap-weighted structure heavily favoring low-yielding Eli Lilly.
  • For significantly higher income, investors are advised to directly hold AbbVie, Johnson & Johnson, and Bristol Myers Squibb, which offer yields ranging from 2% to over 3.75%.
Explore SPY price history & advisor snapshot

These are separate market snapshots and may predate this story. Check the data period, generation time and expiry before using them in your research.

Stored market data

SPY price history

757.39 +12.36% over the displayed period

Advisor Snapshot

Unlock Member-Only Insights

Reserved for TradingNews24 members. Log in or create a free account to access market signals and exclusive tools.

Browse August 2026 news → ← Back to market news

Market analysis for educational use. Trading involves risk. AI sentiment is not financial advice.

Methodology · Risk disclosure